A drug with the SMILES Cc1nc2ccccn2c1-c1ccnc(SCc2ccc(Cl)cc2)n1 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 15.775%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
Cc1nc2ccccn2c1-c1ccnc(SCc2ccc(Cl)cc2)n1
Cc1nc2ccccn2c1-c1ccnc(SCc2ccc(Cl)cc2)n1
3-[2-[(4-chlorophenyl)methylsulfanyl]pyrimidin-4-yl]-2-methylimidazo[1,2-a]pyridine